Rhumbline Advisers STRONGBRIDGE BIOPHARMA Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q3 2024

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 05, 2021
SELL
N/A
-29,836 Closed
0 $0
Q1 2021

May 06, 2021
BUY
N/A
100 Added 0.34%
29,836 $82,000
Q4 2020

Feb 10, 2021
BUY
N/A
4,595 Added 18.28%
29,736 $72,000
Q3 2020

Nov 12, 2020
SELL
N/A
-8,645 Reduced 25.59%
25,141 $53,000
Q2 2020

Aug 13, 2020
SELL
N/A
-5,131 Reduced 13.18%
33,786 $128,000
Q4 2019

Feb 05, 2020
BUY
N/A
606 Added 1.58%
38,917 $81,000
Q3 2019

Oct 23, 2019
BUY
N/A
4,811 Added 14.36%
38,311 $92,000
Q2 2019

Aug 14, 2019
BUY
N/A
33,500 New
33,500 $105,000
Q2 2018

Aug 06, 2018
SELL
N/A
-21,661 Closed
0 $0
Q1 2018

May 02, 2018
BUY
N/A
4,576 Added 26.78%
21,661 $192,000
Q4 2017

Feb 09, 2018
SELL
N/A
-4,771 Reduced 21.83%
17,085 $124,000
Q3 2017

Nov 06, 2017
BUY
N/A
21,856
21,856 $151,000
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email